NCT03670667View on ClinicalTrials.gov

A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

CompletedOBSERVATIONAL
Enrollment

1,132

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Non-Interventional

Non-Interventional

OTHER

Non-Interventional

Non-Interventional

OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

08540

Local Institution, Princeton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03670667 - A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents | Biotech Hunter | Biotech Hunter